Monthly Prescribing Reference11h
Neoadjuvant/Adjuvant Opdivo Approved for Resectable NSCLC
The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.
Medscape12h
Nivolumab NSCLC Approval Expanded to Perioperative Setting
The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with ...
Targeted Oncology16h
FDA Approves Perioperative Nivolumab in Resectable NSCLC
The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...
Oncology Nurse Advisor16h
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI Therapy
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.
Labroots21h
Uncovering a Mechanism of Immunotherapy Response in Lung Cancer
When cancer cells mutate, they produce small peptides called neoantigens.  Because neoantigens remain relatively unique to ...
MedPage Today1d
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer
Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show ...
Cure Today1d
Longer Time Until Recurrence Associated With Better Melanoma Outcomes
An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved ...
Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy
A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for ...
Armed robbery in Revesby2d
Cleveland Clinic Maps Immune Response in Cancer Therapy
A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic's Global Center for ...
Targeted Oncology2d
Tivozanib Outperforms ICI Combo in Advanced RCC
Toni Choueiri, MD, discusses the rationale behind the drug combination of tivozanib and nivolumab in the TiNivo-2 study.
Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer
Investigational immunotherapy, VTP-300, is being evaluated as part of a potential functional cure regimen for chronic ...
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer
The NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III ...